Literature DB >> 6215895

Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.

D N Wright, D F Welch, B A Saxon, S J Clark, J M Matsen.   

Abstract

Cefoperazone agar dilution minimal inhibitory concentration (MIC) susceptibility results were compared with zones of inhibition produced by disk diffusion susceptibility testing. Disks containing 30, 50, 75, and 100 micrograms of cefoperazone were tested for purposes of regression line comparisons and error rate-bounded analysis. Results suggest that if the MIC equivalent of susceptibility is 32 micrograms/ml, either a 50-micrograms disk with zone sizes of susceptibility (S) greater than or equal to 15 mm and resistance (R) less than or equal to 12 mm or a 75-micrograms disk with zone sizes of S greater than or equal to 17 mm and R less than or equal to 14 mm may be appropriate. If the MIC equivalent of susceptibility is 64 micrograms/ml, this would dictate use of a 75-micrograms disk with zone sizes of S greater than or equal to 17 mm and R less than or equal to 12 mm. Disks containing either less than or equal to 30 or greater than or equal to 100 micrograms of cefoperazone did not adequately discriminate among susceptible and resistant bacterial strains at either the 32- or 64-micrograms/ml MIC equivalent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215895      PMCID: PMC183771          DOI: 10.1128/AAC.22.3.493

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Diffusion disk susceptibility testing with cefotaxime.

Authors:  N Aswapokee; P Aswapokee; H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

2.  Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

3.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

4.  In vitro evaluation of cefoperazone.

Authors:  A M Hinkle; B M LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

  4 in total
  1 in total

1.  Biographical feature: John Matsen, M.D.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.